Active Ingredient History
Sulodexide, traded as Aterina, is a highly purified mixture of glycosaminoglycans composed of low molecular weight heparin (80%) and dermatan sulfate (20%). Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Aged (Phase 3)
Albuminuria (Phase 4)
Anticoagulants (Phase 3)
COVID-19 (Phase 2/Phase 3)
Diabetes Mellitus (Phase 4)
Diabetic Nephropathies (Phase 4)
Diabetic Retinopathy (Phase 2)
Drug Therapy (Phase 3)
Minimally Invasive Surgical Procedures (Phase 3)
Peripheral Arterial Disease (Phase 3)
Postthrombotic Syndrome (Phase 4)
Prostatic Diseases (Phase 3)
Prostatic Hyperplasia (Phase 3)
Renal Insufficiency, Chronic (Phase 3)
Tinnitus (Phase 2)
Venous Thromboembolism (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue